Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZEB1
|
ENSG00000148516.17 | zinc finger E-box binding homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZEB1 | hg19_v2_chr10_+_31608054_31608156 | -0.05 | 7.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_7165662 | 22.16 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
chr19_+_6464243 | 19.65 |
ENST00000600229.1
ENST00000356762.3 |
CRB3
|
crumbs homolog 3 (Drosophila) |
chr19_-_10697895 | 17.03 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
chr1_-_27286897 | 14.53 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
chr19_+_6464502 | 13.48 |
ENST00000308243.7
|
CRB3
|
crumbs homolog 3 (Drosophila) |
chr8_+_95653302 | 12.90 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
chr8_+_120220561 | 12.52 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
chr7_-_16921601 | 12.32 |
ENST00000402239.3
ENST00000310398.2 ENST00000414935.1 |
AGR3
|
anterior gradient 3 |
chr8_+_95653427 | 12.11 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr14_-_65409502 | 11.67 |
ENST00000389614.5
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal) |
chr8_+_95653373 | 11.45 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr16_+_68771128 | 11.34 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
chr14_-_65409438 | 11.15 |
ENST00000557049.1
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal) |
chr5_+_68788594 | 10.92 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
chr8_+_102504651 | 10.74 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
chr20_+_44098385 | 10.44 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chr20_+_44098346 | 10.14 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr17_-_39684550 | 10.03 |
ENST00000455635.1
ENST00000361566.3 |
KRT19
|
keratin 19 |
chr12_+_7072354 | 9.94 |
ENST00000537269.1
|
U47924.27
|
U47924.27 |
chr7_-_16844611 | 9.64 |
ENST00000401412.1
ENST00000419304.2 |
AGR2
|
anterior gradient 2 |
chr19_+_38755042 | 9.35 |
ENST00000301244.7
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr19_+_38755203 | 9.12 |
ENST00000587090.1
ENST00000454580.3 |
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr21_-_42879909 | 9.10 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
chr19_+_38755237 | 8.58 |
ENST00000587516.1
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr7_-_73184588 | 8.31 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
chr12_-_53298841 | 8.20 |
ENST00000293308.6
|
KRT8
|
keratin 8 |
chr8_+_102504979 | 8.12 |
ENST00000395927.1
|
GRHL2
|
grainyhead-like 2 (Drosophila) |
chr17_-_36105009 | 8.04 |
ENST00000560016.1
ENST00000427275.2 ENST00000561193.1 |
HNF1B
|
HNF1 homeobox B |
chr12_-_6484715 | 7.78 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr4_-_77819002 | 7.65 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
chr15_+_41136586 | 7.64 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr1_-_153588765 | 7.58 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
chr21_-_42880075 | 7.56 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
chr19_+_55587266 | 7.53 |
ENST00000201647.6
ENST00000540810.1 |
EPS8L1
|
EPS8-like 1 |
chr3_-_121740969 | 7.53 |
ENST00000393631.1
ENST00000273691.3 ENST00000344209.5 |
ILDR1
|
immunoglobulin-like domain containing receptor 1 |
chr12_-_6484376 | 7.52 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr1_-_21948906 | 7.42 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr14_-_61747949 | 7.38 |
ENST00000355702.2
|
TMEM30B
|
transmembrane protein 30B |
chr12_+_52626898 | 7.27 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
chr7_+_140103842 | 7.22 |
ENST00000495590.1
ENST00000275874.5 ENST00000537763.1 |
RAB19
|
RAB19, member RAS oncogene family |
chr1_-_153588334 | 7.21 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
chr1_+_200863949 | 7.10 |
ENST00000413687.2
|
C1orf106
|
chromosome 1 open reading frame 106 |
chr8_-_144815966 | 7.03 |
ENST00000388913.3
|
FAM83H
|
family with sequence similarity 83, member H |
chr19_+_7660716 | 6.97 |
ENST00000160298.4
ENST00000446248.2 |
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3 |
chr17_+_37894179 | 6.95 |
ENST00000577695.1
ENST00000309156.4 ENST00000309185.3 |
GRB7
|
growth factor receptor-bound protein 7 |
chr11_-_14993819 | 6.68 |
ENST00000396372.2
ENST00000361010.3 ENST00000359642.3 ENST00000331587.4 |
CALCA
|
calcitonin-related polypeptide alpha |
chr11_+_34642656 | 6.58 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chr2_-_219925189 | 6.50 |
ENST00000295731.6
|
IHH
|
indian hedgehog |
chr5_-_147211226 | 6.36 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
chr21_-_31588365 | 6.34 |
ENST00000399899.1
|
CLDN8
|
claudin 8 |
chr1_+_95285896 | 6.32 |
ENST00000446120.2
ENST00000271227.6 ENST00000527077.1 ENST00000529450.1 |
SLC44A3
|
solute carrier family 44, member 3 |
chr11_+_394196 | 6.28 |
ENST00000331563.2
ENST00000531857.1 |
PKP3
|
plakophilin 3 |
chr11_+_27062502 | 6.28 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr17_-_46035187 | 6.26 |
ENST00000300557.2
|
PRR15L
|
proline rich 15-like |
chr11_+_27062272 | 6.25 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr2_-_166651191 | 6.12 |
ENST00000392701.3
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr11_-_64612041 | 6.07 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
chr19_+_35607166 | 6.06 |
ENST00000604255.1
ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr16_+_23194033 | 5.97 |
ENST00000300061.2
|
SCNN1G
|
sodium channel, non-voltage-gated 1, gamma subunit |
chr1_-_207119738 | 5.93 |
ENST00000356495.4
|
PIGR
|
polymeric immunoglobulin receptor |
chr14_-_67859422 | 5.92 |
ENST00000556532.1
|
PLEK2
|
pleckstrin 2 |
chr21_-_31588338 | 5.83 |
ENST00000286809.1
|
CLDN8
|
claudin 8 |
chr1_-_209979375 | 5.81 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
chr4_+_25657444 | 5.80 |
ENST00000504570.1
ENST00000382051.3 |
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 2 |
chr1_-_43751276 | 5.79 |
ENST00000423420.1
|
C1orf210
|
chromosome 1 open reading frame 210 |
chr2_-_20424844 | 5.79 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
chr1_-_201368653 | 5.78 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
chr17_+_37894570 | 5.76 |
ENST00000394211.3
|
GRB7
|
growth factor receptor-bound protein 7 |
chr15_+_41136734 | 5.75 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr2_-_166651152 | 5.70 |
ENST00000431484.1
ENST00000412248.1 |
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr19_+_35532612 | 5.61 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
chr1_+_3370990 | 5.57 |
ENST00000378378.4
|
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
chr1_-_155162658 | 5.57 |
ENST00000368389.2
ENST00000368396.4 ENST00000343256.5 ENST00000342482.4 ENST00000368398.3 ENST00000368390.3 ENST00000337604.5 ENST00000368392.3 ENST00000438413.1 ENST00000368393.3 ENST00000457295.2 ENST00000338684.5 ENST00000368395.1 |
MUC1
|
mucin 1, cell surface associated |
chr15_+_41136216 | 5.56 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr1_+_60280458 | 5.56 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
chr19_-_54676884 | 5.52 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
chr19_+_35606777 | 5.51 |
ENST00000604404.1
ENST00000435734.2 ENST00000603181.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr1_-_161059380 | 5.47 |
ENST00000368012.3
|
PVRL4
|
poliovirus receptor-related 4 |
chr19_-_54676846 | 5.47 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
chr2_-_31030277 | 5.46 |
ENST00000534090.2
ENST00000295055.8 |
CAPN13
|
calpain 13 |
chr6_-_136871957 | 5.43 |
ENST00000354570.3
|
MAP7
|
microtubule-associated protein 7 |
chr19_-_36001286 | 5.43 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
chr1_+_16348366 | 5.42 |
ENST00000375692.1
ENST00000420078.1 |
CLCNKA
|
chloride channel, voltage-sensitive Ka |
chr1_-_201368707 | 5.40 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
chr11_+_27062860 | 5.37 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr14_-_61748550 | 5.34 |
ENST00000555868.1
|
TMEM30B
|
transmembrane protein 30B |
chr17_-_74023474 | 5.31 |
ENST00000301607.3
|
EVPL
|
envoplakin |
chr1_-_59043166 | 5.27 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
chr19_+_35739597 | 5.26 |
ENST00000361790.3
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr19_+_35739782 | 5.22 |
ENST00000347609.4
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr19_+_35739631 | 5.22 |
ENST00000602003.1
ENST00000360798.3 ENST00000354900.3 |
LSR
|
lipolysis stimulated lipoprotein receptor |
chr15_+_45722727 | 5.19 |
ENST00000396650.2
ENST00000558435.1 ENST00000344300.3 |
C15orf48
|
chromosome 15 open reading frame 48 |
chr2_+_47596287 | 5.18 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
chr1_-_209979465 | 5.15 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
chr11_+_706113 | 5.10 |
ENST00000318562.8
ENST00000533256.1 ENST00000534755.1 |
EPS8L2
|
EPS8-like 2 |
chr8_-_6735451 | 5.09 |
ENST00000297439.3
|
DEFB1
|
defensin, beta 1 |
chr19_-_11529225 | 5.06 |
ENST00000567431.1
|
RGL3
|
ral guanine nucleotide dissociation stimulator-like 3 |
chr1_+_156030937 | 5.01 |
ENST00000361084.5
|
RAB25
|
RAB25, member RAS oncogene family |
chr12_+_56473628 | 4.99 |
ENST00000549282.1
ENST00000549061.1 ENST00000267101.3 |
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
chr16_-_68269971 | 4.96 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
chr4_-_40632605 | 4.95 |
ENST00000514014.1
|
RBM47
|
RNA binding motif protein 47 |
chr17_-_74023291 | 4.88 |
ENST00000586740.1
|
EVPL
|
envoplakin |
chr6_+_27215471 | 4.86 |
ENST00000421826.2
|
PRSS16
|
protease, serine, 16 (thymus) |
chr1_+_16348497 | 4.81 |
ENST00000439316.2
|
CLCNKA
|
chloride channel, voltage-sensitive Ka |
chr21_-_43187231 | 4.79 |
ENST00000332512.3
ENST00000352483.2 |
RIPK4
|
receptor-interacting serine-threonine kinase 4 |
chr19_+_45281118 | 4.78 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr20_-_18038521 | 4.77 |
ENST00000278780.6
|
OVOL2
|
ovo-like zinc finger 2 |
chr1_+_16348525 | 4.75 |
ENST00000331433.4
|
CLCNKA
|
chloride channel, voltage-sensitive Ka |
chr14_-_106330458 | 4.75 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
chr4_-_74486217 | 4.72 |
ENST00000335049.5
ENST00000307439.5 |
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr2_-_20425158 | 4.63 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
chr2_-_56150910 | 4.59 |
ENST00000424836.2
ENST00000438672.1 ENST00000440439.1 ENST00000429909.1 ENST00000424207.1 ENST00000452337.1 ENST00000355426.3 ENST00000439193.1 ENST00000421664.1 |
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
chr5_+_68711209 | 4.59 |
ENST00000512803.1
|
MARVELD2
|
MARVEL domain containing 2 |
chr15_+_41136369 | 4.58 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr17_+_73521763 | 4.58 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
chr16_-_2908155 | 4.56 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
chr2_-_220034712 | 4.56 |
ENST00000409370.2
ENST00000430764.1 ENST00000409878.3 |
SLC23A3
|
solute carrier family 23, member 3 |
chr7_+_73242490 | 4.49 |
ENST00000431918.1
|
CLDN4
|
claudin 4 |
chr3_-_48471454 | 4.48 |
ENST00000296440.6
ENST00000448774.2 |
PLXNB1
|
plexin B1 |
chr6_+_27215494 | 4.47 |
ENST00000230582.3
|
PRSS16
|
protease, serine, 16 (thymus) |
chr19_-_36499521 | 4.46 |
ENST00000397428.3
ENST00000503121.1 ENST00000340477.5 ENST00000324444.3 ENST00000490730.1 |
SYNE4
|
spectrin repeat containing, nuclear envelope family member 4 |
chr11_+_71903169 | 4.43 |
ENST00000393676.3
|
FOLR1
|
folate receptor 1 (adult) |
chr7_+_73242069 | 4.41 |
ENST00000435050.1
|
CLDN4
|
claudin 4 |
chr16_-_3086927 | 4.37 |
ENST00000572449.1
|
CCDC64B
|
coiled-coil domain containing 64B |
chr5_+_167718604 | 4.35 |
ENST00000265293.4
|
WWC1
|
WW and C2 domain containing 1 |
chr14_-_67878917 | 4.32 |
ENST00000216446.4
|
PLEK2
|
pleckstrin 2 |
chr1_+_201979645 | 4.32 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr9_-_116861337 | 4.31 |
ENST00000374118.3
|
KIF12
|
kinesin family member 12 |
chr11_+_65554493 | 4.29 |
ENST00000335987.3
|
OVOL1
|
ovo-like zinc finger 1 |
chr2_+_27665232 | 4.27 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
chr11_+_45944190 | 4.22 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
chr17_+_9548845 | 4.19 |
ENST00000570475.1
ENST00000285199.7 |
USP43
|
ubiquitin specific peptidase 43 |
chr5_+_76114758 | 4.19 |
ENST00000514165.1
ENST00000296677.4 |
F2RL1
|
coagulation factor II (thrombin) receptor-like 1 |
chr19_+_35739897 | 4.14 |
ENST00000605618.1
ENST00000427250.1 ENST00000601623.1 |
LSR
|
lipolysis stimulated lipoprotein receptor |
chr22_+_45148432 | 4.12 |
ENST00000389774.2
ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8
|
Rho GTPase activating protein 8 |
chr12_+_6419877 | 4.09 |
ENST00000536531.1
|
PLEKHG6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
chr3_+_105086056 | 4.06 |
ENST00000472644.2
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr5_-_138725594 | 4.05 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
chr19_+_35739280 | 4.04 |
ENST00000602122.1
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr16_+_68678739 | 4.02 |
ENST00000264012.4
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr6_-_31846744 | 4.01 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
chr8_+_95653840 | 3.99 |
ENST00000520385.1
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr15_+_41136263 | 3.98 |
ENST00000568823.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chrX_+_105969893 | 3.96 |
ENST00000255499.2
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr11_+_706219 | 3.96 |
ENST00000533500.1
|
EPS8L2
|
EPS8-like 2 |
chr1_+_183155373 | 3.95 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
chr5_+_68711023 | 3.91 |
ENST00000515844.1
|
MARVELD2
|
MARVEL domain containing 2 |
chr11_+_560956 | 3.91 |
ENST00000397582.3
ENST00000344375.4 ENST00000397583.3 |
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
chr7_+_117120017 | 3.90 |
ENST00000003084.6
ENST00000454343.1 |
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
chrX_+_70443050 | 3.89 |
ENST00000361726.6
|
GJB1
|
gap junction protein, beta 1, 32kDa |
chr5_+_89854595 | 3.89 |
ENST00000405460.2
|
GPR98
|
G protein-coupled receptor 98 |
chr12_-_53343602 | 3.87 |
ENST00000546897.1
ENST00000552551.1 |
KRT8
|
keratin 8 |
chr6_-_47010061 | 3.87 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
chr3_-_49459878 | 3.87 |
ENST00000546031.1
ENST00000458307.2 ENST00000430521.1 |
AMT
|
aminomethyltransferase |
chr19_-_36001113 | 3.86 |
ENST00000434389.1
|
DMKN
|
dermokine |
chr19_+_11350278 | 3.86 |
ENST00000252453.8
|
C19orf80
|
chromosome 19 open reading frame 80 |
chr20_+_49348109 | 3.86 |
ENST00000396039.1
|
PARD6B
|
par-6 family cell polarity regulator beta |
chr20_+_49348081 | 3.86 |
ENST00000371610.2
|
PARD6B
|
par-6 family cell polarity regulator beta |
chr18_-_47721447 | 3.84 |
ENST00000285039.7
|
MYO5B
|
myosin VB |
chr1_-_43751230 | 3.83 |
ENST00000523677.1
|
C1orf210
|
chromosome 1 open reading frame 210 |
chr2_+_27665289 | 3.81 |
ENST00000407293.1
|
KRTCAP3
|
keratinocyte associated protein 3 |
chr1_-_40367668 | 3.76 |
ENST00000397332.2
ENST00000429311.1 |
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog |
chr10_+_43867077 | 3.76 |
ENST00000476166.1
|
FXYD4
|
FXYD domain containing ion transport regulator 4 |
chr5_-_54281491 | 3.75 |
ENST00000381405.4
|
ESM1
|
endothelial cell-specific molecule 1 |
chr5_-_138725560 | 3.73 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
chr6_-_132722604 | 3.70 |
ENST00000392401.3
ENST00000367963.3 |
MOXD1
|
monooxygenase, DBH-like 1 |
chr11_-_560703 | 3.68 |
ENST00000441853.1
ENST00000329451.3 |
C11orf35
|
chromosome 11 open reading frame 35 |
chr1_-_47655686 | 3.67 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
chr16_+_68678892 | 3.64 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr2_-_89417335 | 3.63 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr19_+_3721719 | 3.59 |
ENST00000589378.1
ENST00000382008.3 |
TJP3
|
tight junction protein 3 |
chr16_-_20367584 | 3.58 |
ENST00000570689.1
|
UMOD
|
uromodulin |
chr2_-_241835561 | 3.57 |
ENST00000388934.4
|
C2orf54
|
chromosome 2 open reading frame 54 |
chr2_+_234602305 | 3.55 |
ENST00000406651.1
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6 |
chr1_-_207206092 | 3.54 |
ENST00000359470.5
ENST00000461135.2 |
C1orf116
|
chromosome 1 open reading frame 116 |
chr1_+_27189631 | 3.53 |
ENST00000339276.4
|
SFN
|
stratifin |
chr12_-_103310987 | 3.50 |
ENST00000307000.2
|
PAH
|
phenylalanine hydroxylase |
chr4_+_106816644 | 3.49 |
ENST00000506666.1
ENST00000503451.1 |
NPNT
|
nephronectin |
chr16_-_86542652 | 3.49 |
ENST00000599749.1
|
FENDRR
|
FOXF1 adjacent non-coding developmental regulatory RNA |
chrX_-_3264682 | 3.47 |
ENST00000217939.6
|
MXRA5
|
matrix-remodelling associated 5 |
chr19_-_7990991 | 3.45 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
chr1_-_85514120 | 3.44 |
ENST00000370589.2
ENST00000341115.4 ENST00000370587.1 |
MCOLN3
|
mucolipin 3 |
chr8_-_79717750 | 3.42 |
ENST00000263851.4
ENST00000379113.2 |
IL7
|
interleukin 7 |
chr1_+_16375284 | 3.42 |
ENST00000375667.3
|
CLCNKB
|
chloride channel, voltage-sensitive Kb |
chr11_+_706595 | 3.42 |
ENST00000531348.1
ENST00000530636.1 |
EPS8L2
|
EPS8-like 2 |
chr16_+_84402098 | 3.41 |
ENST00000262429.4
ENST00000416219.2 |
ATP2C2
|
ATPase, Ca++ transporting, type 2C, member 2 |
chr4_-_74486109 | 3.37 |
ENST00000395777.2
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr7_-_98030360 | 3.37 |
ENST00000005260.8
|
BAIAP2L1
|
BAI1-associated protein 2-like 1 |
chr2_+_47596634 | 3.37 |
ENST00000419334.1
|
EPCAM
|
epithelial cell adhesion molecule |
chr6_-_41715128 | 3.36 |
ENST00000356667.4
ENST00000373025.3 ENST00000425343.2 |
PGC
|
progastricsin (pepsinogen C) |
chr16_+_68679193 | 3.35 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr22_+_23229960 | 3.34 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr19_+_35606692 | 3.34 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chrX_+_48620147 | 3.34 |
ENST00000303227.6
|
GLOD5
|
glyoxalase domain containing 5 |
chr16_-_20364030 | 3.34 |
ENST00000396134.2
ENST00000573567.1 ENST00000570757.1 ENST00000424589.1 ENST00000302509.4 ENST00000571174.1 ENST00000576688.1 |
UMOD
|
uromodulin |
chr1_-_55266926 | 3.33 |
ENST00000371276.4
|
TTC22
|
tetratricopeptide repeat domain 22 |
chr19_+_55591743 | 3.32 |
ENST00000588359.1
ENST00000245618.5 |
EPS8L1
|
EPS8-like 1 |
chr4_+_85504075 | 3.32 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
chr17_-_31204124 | 3.31 |
ENST00000579584.1
ENST00000318217.5 ENST00000583621.1 |
MYO1D
|
myosin ID |
chr3_-_45187843 | 3.29 |
ENST00000296129.1
ENST00000425231.2 |
CDCP1
|
CUB domain containing protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 45.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
4.3 | 8.6 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
4.0 | 23.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.5 | 10.4 | GO:0048627 | myoblast development(GO:0048627) |
3.1 | 12.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
3.1 | 9.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
3.1 | 3.1 | GO:0032402 | melanosome transport(GO:0032402) |
2.8 | 11.0 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
2.7 | 2.7 | GO:0044062 | regulation of excretion(GO:0044062) |
2.6 | 2.6 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
2.5 | 7.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
2.2 | 6.7 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
2.1 | 14.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
2.0 | 9.8 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
1.8 | 5.4 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
1.8 | 12.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.7 | 13.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.7 | 11.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.6 | 6.6 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
1.6 | 23.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.6 | 29.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.5 | 7.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.5 | 19.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.5 | 54.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.4 | 7.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.4 | 4.2 | GO:0048925 | lateral line system development(GO:0048925) |
1.4 | 19.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.4 | 5.4 | GO:0070662 | mast cell proliferation(GO:0070662) |
1.3 | 4.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
1.3 | 5.2 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.3 | 1.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.3 | 7.6 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
1.3 | 16.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.3 | 8.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.2 | 8.4 | GO:1902896 | terminal web assembly(GO:1902896) |
1.2 | 1.2 | GO:1903970 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
1.2 | 8.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
1.2 | 7.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.1 | 4.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.1 | 1.1 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
1.1 | 4.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.1 | 3.4 | GO:0042710 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) positive regulation of bone mineralization involved in bone maturation(GO:1900159) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
1.1 | 1.1 | GO:0060482 | lobar bronchus development(GO:0060482) |
1.1 | 3.2 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
1.1 | 3.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
1.0 | 3.1 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
1.0 | 5.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
1.0 | 1.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.0 | 2.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.0 | 17.0 | GO:0002934 | desmosome organization(GO:0002934) |
1.0 | 4.9 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
1.0 | 3.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.0 | 1.0 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
1.0 | 2.9 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
1.0 | 10.5 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.9 | 2.8 | GO:0043318 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
0.9 | 3.8 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.9 | 13.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.9 | 4.7 | GO:0048749 | compound eye development(GO:0048749) |
0.9 | 12.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.9 | 9.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.9 | 1.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.9 | 14.4 | GO:0055062 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
0.9 | 7.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.9 | 5.3 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
0.9 | 5.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.9 | 2.6 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.9 | 7.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.9 | 5.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.9 | 3.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.9 | 1.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.8 | 2.5 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.8 | 3.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.8 | 3.3 | GO:0044691 | tooth eruption(GO:0044691) |
0.8 | 4.2 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.8 | 5.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.8 | 3.3 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.8 | 1.6 | GO:0072039 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.8 | 6.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.8 | 2.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.8 | 10.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.8 | 2.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.8 | 14.1 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.8 | 3.9 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.8 | 2.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.8 | 12.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.7 | 4.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.7 | 3.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.7 | 14.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 7.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.7 | 5.0 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.7 | 3.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 7.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.7 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.7 | 1.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.7 | 2.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.7 | 4.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.7 | 1.4 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.7 | 4.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.7 | 2.0 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.7 | 3.3 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 6.7 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.7 | 7.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.7 | 0.7 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
0.7 | 2.0 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.7 | 10.5 | GO:0015871 | choline transport(GO:0015871) |
0.6 | 1.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 0.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.6 | 3.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.6 | 3.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.6 | 3.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.6 | 1.9 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.6 | 3.1 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.6 | 3.7 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.6 | 1.8 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.6 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 2.9 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.6 | 2.9 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.6 | 17.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.6 | 8.0 | GO:1901166 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.6 | 0.6 | GO:0097069 | response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.6 | 0.6 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.6 | 4.4 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.6 | 54.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.5 | 3.3 | GO:0060214 | endocardium formation(GO:0060214) |
0.5 | 3.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 2.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.5 | 2.1 | GO:0003335 | corneocyte development(GO:0003335) |
0.5 | 1.5 | GO:1903489 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
0.5 | 4.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.5 | 8.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.5 | 1.5 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.5 | 2.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.5 | GO:0031247 | actin rod assembly(GO:0031247) |
0.5 | 2.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.5 | 3.9 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 1.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.5 | 1.4 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.5 | 1.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.5 | 2.8 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.5 | 1.9 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.5 | 1.8 | GO:0045401 | response to molecule of fungal origin(GO:0002238) regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
0.5 | 1.8 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
0.4 | 1.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.4 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 2.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.4 | 1.3 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 5.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 8.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.4 | 5.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.4 | 6.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.4 | 1.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.4 | 4.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 66.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 2.8 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.4 | 2.4 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.4 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 0.8 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.4 | 1.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 14.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 1.9 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 3.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 0.4 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.4 | 4.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.4 | 6.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 8.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.9 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.4 | 1.5 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.4 | 3.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.4 | 5.1 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 2.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.4 | 1.1 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
0.4 | 2.2 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.4 | 1.1 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.4 | 11.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.4 | 1.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 0.7 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.4 | 1.4 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.3 | 1.0 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
0.3 | 3.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 1.0 | GO:2000449 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.3 | 3.8 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.3 | 1.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.3 | 11.9 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.3 | 8.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.3 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.3 | 0.3 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.3 | 1.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 1.7 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 0.7 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.3 | 6.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 1.6 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 6.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 4.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.3 | 2.9 | GO:1902903 | regulation of fibril organization(GO:1902903) |
0.3 | 9.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 4.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.3 | 1.6 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.3 | 2.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 1.5 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 1.2 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) negative regulation of glomerulus development(GO:0090194) |
0.3 | 3.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 0.9 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.3 | 12.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.3 | 0.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.3 | 1.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.3 | 0.6 | GO:0002840 | B cell cytokine production(GO:0002368) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.3 | 0.6 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.3 | 1.2 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) deoxyribonucleoside diphosphate metabolic process(GO:0009186) dADP metabolic process(GO:0046056) dGDP metabolic process(GO:0046066) |
0.3 | 2.1 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.3 | 2.9 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.3 | 1.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 0.9 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.3 | 3.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 2.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.3 | 1.1 | GO:1903382 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.3 | 4.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.9 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.3 | 0.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 1.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 4.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 1.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.3 | 1.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.3 | 2.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.5 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.3 | 3.6 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.3 | 1.9 | GO:0051962 | positive regulation of nervous system development(GO:0051962) |
0.3 | 2.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.3 | 1.6 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 1.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.3 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 1.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 19.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.3 | 5.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 2.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 18.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.3 | 6.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 3.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 1.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.3 | 0.8 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.3 | 1.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 1.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 4.5 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.3 | 1.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 1.0 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.2 | 1.7 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.2 | 4.4 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 1.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 1.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.2 | 3.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 6.3 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.7 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.2 | 1.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.2 | 1.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 41.9 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.2 | 1.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.2 | 0.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.2 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.9 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 1.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.2 | 2.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 0.7 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.2 | 1.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.5 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.2 | 3.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 1.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 2.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 2.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 2.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 1.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 6.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 3.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 3.0 | GO:0030183 | B cell differentiation(GO:0030183) |
0.2 | 2.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 6.8 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 3.8 | GO:0097205 | renal filtration(GO:0097205) |
0.2 | 1.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 1.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 1.0 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.2 | 0.8 | GO:0070997 | neuron death(GO:0070997) |
0.2 | 4.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 1.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.2 | 0.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 1.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 3.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 3.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.2 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.9 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.2 | 3.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 6.7 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 2.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.9 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.2 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.9 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.2 | 3.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.2 | 0.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 0.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.2 | 4.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 10.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.4 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.2 | 2.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.7 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.2 | 2.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 3.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.5 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.2 | 3.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 3.6 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 0.9 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.2 | 0.5 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.2 | 0.5 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.2 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 1.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 0.7 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.2 | 0.5 | GO:1990637 | response to prolactin(GO:1990637) |
0.2 | 3.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 2.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.7 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.2 | 0.8 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 0.8 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.2 | 1.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 10.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.2 | 1.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 1.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.2 | 1.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.5 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 0.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.2 | 2.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 0.5 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.2 | 1.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.8 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.2 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 1.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 2.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 1.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 0.5 | GO:0044209 | AMP salvage(GO:0044209) |
0.1 | 2.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 1.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 2.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.6 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 1.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.4 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.1 | 2.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.9 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.4 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.1 | 0.8 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 1.7 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.1 | 2.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 1.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 1.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 1.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 2.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 2.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 3.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 3.0 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.5 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 1.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 7.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.8 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.5 | GO:0050925 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) negative regulation of negative chemotaxis(GO:0050925) |
0.1 | 0.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 4.6 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 2.4 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.1 | 1.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.4 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 2.7 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 1.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 17.9 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 1.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.4 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.1 | 0.8 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 1.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 | 0.8 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 1.2 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.1 | 3.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.1 | 0.5 | GO:1904044 | response to aldosterone(GO:1904044) |
0.1 | 4.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 1.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.5 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.1 | 1.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.1 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 1.9 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.1 | 0.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 1.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.1 | 1.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 3.6 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 0.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 3.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.5 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 2.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.1 | 0.1 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.1 | 0.3 | GO:0021503 | neural fold bending(GO:0021503) |
0.1 | 1.0 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.8 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 1.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 1.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.3 | GO:0071529 | cementum mineralization(GO:0071529) |
0.1 | 0.3 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.6 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 1.1 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 1.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.1 | 0.4 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 1.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 2.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.9 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 1.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 2.8 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 1.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 1.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 1.3 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 1.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.4 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 1.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 1.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.6 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 2.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.4 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.3 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 1.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.4 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.1 | 2.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 2.7 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.8 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 3.6 | GO:0045453 | bone resorption(GO:0045453) |
0.1 | 0.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 1.9 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 2.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.4 | GO:0019303 | D-ribose metabolic process(GO:0006014) D-ribose catabolic process(GO:0019303) |
0.1 | 0.9 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.6 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 0.4 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.2 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.1 | 0.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 0.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.9 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 | 7.4 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.2 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.1 | 0.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.9 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.4 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.1 | 0.5 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.1 | 0.5 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 1.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 1.8 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 3.9 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 1.8 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.7 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.7 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
0.1 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.3 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.1 | 1.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.2 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.3 | GO:0021678 | third ventricle development(GO:0021678) |
0.1 | 1.9 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.5 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.7 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 1.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.4 | GO:0019755 | urea transport(GO:0015840) one-carbon compound transport(GO:0019755) urea transmembrane transport(GO:0071918) |
0.1 | 0.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.3 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.8 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 1.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 5.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 3.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.4 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.1 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.2 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.1 | 1.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 1.0 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.2 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.1 | 0.1 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.1 | 1.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 2.8 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 1.2 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 6.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 1.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.2 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 3.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.7 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.5 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.1 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.1 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 1.0 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 1.2 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.0 | 0.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.1 | GO:0071380 | response to prostaglandin E(GO:0034695) cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 1.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 1.7 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.6 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.0 | 0.6 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 1.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.2 | GO:0051572 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
0.0 | 0.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.1 | GO:0045226 | hyaluranon cable assembly(GO:0036118) extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.0 | 0.3 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.0 | 0.3 | GO:1904646 | cellular response to beta-amyloid(GO:1904646) |
0.0 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.2 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 0.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.2 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.0 | 0.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.5 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.0 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.0 | 1.2 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.0 | 0.8 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.0 | 0.2 | GO:0018958 | phenol-containing compound metabolic process(GO:0018958) |
0.0 | 0.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.6 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.0 | 0.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.5 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.2 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.0 | 0.4 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 | 0.2 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.1 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.0 | 0.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 1.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 2.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 2.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 2.0 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.3 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 1.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.2 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.0 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.5 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.0 | 0.3 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.8 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.3 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.4 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.2 | GO:0060356 | leucine import(GO:0060356) |
0.0 | 0.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.4 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 1.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.0 | 0.6 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 3.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
0.0 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.2 | GO:0097484 | dendrite extension(GO:0097484) |
0.0 | 0.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.4 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.3 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.0 | 0.1 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.0 | 0.4 | GO:0045939 | negative regulation of steroid biosynthetic process(GO:0010894) negative regulation of steroid metabolic process(GO:0045939) |
0.0 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.4 | GO:0000732 | strand displacement(GO:0000732) |
0.0 | 0.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.1 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.4 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.6 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.0 | GO:1904238 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) pericyte cell differentiation(GO:1904238) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.0 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 1.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 1.1 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 42.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
2.3 | 95.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.7 | 3.3 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
1.5 | 3.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.4 | 5.7 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.3 | 7.6 | GO:1990357 | terminal web(GO:1990357) |
1.1 | 6.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
1.0 | 3.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.0 | 6.1 | GO:0034678 | smooth muscle contractile fiber(GO:0030485) integrin alpha8-beta1 complex(GO:0034678) |
0.9 | 2.8 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.8 | 6.4 | GO:0070695 | FHF complex(GO:0070695) |
0.8 | 3.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.7 | 4.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.7 | 4.2 | GO:1990742 | microvesicle(GO:1990742) |
0.7 | 28.5 | GO:0030057 | desmosome(GO:0030057) |
0.6 | 10.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 1.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.6 | 1.8 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.6 | 1.8 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.6 | 1.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.6 | 2.8 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.6 | 10.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 4.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 7.1 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 1.5 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.5 | 1.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.5 | 16.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 4.2 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.5 | 15.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 2.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.4 | 1.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 10.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 5.7 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.4 | 22.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 1.2 | GO:0001534 | radial spoke(GO:0001534) |
0.4 | 4.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 4.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 12.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 2.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 3.6 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.4 | 0.4 | GO:0044452 | nucleolar part(GO:0044452) |
0.3 | 69.4 | GO:0070160 | occluding junction(GO:0070160) |
0.3 | 2.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.3 | 2.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 30.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 3.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 5.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.6 | GO:0070701 | mucus layer(GO:0070701) |
0.3 | 2.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 4.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 0.9 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.3 | 1.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 2.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 1.4 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.3 | 4.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 5.9 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 18.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 24.6 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 1.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 2.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.3 | 0.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 8.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.7 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 1.2 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 11.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.6 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.2 | 1.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 10.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 1.5 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 3.6 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 27.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.2 | 0.4 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.2 | 2.2 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 16.6 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 5.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 3.7 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.8 | GO:0033011 | perinuclear theca(GO:0033011) |
0.2 | 4.0 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.2 | 1.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 4.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 19.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.5 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.2 | 1.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.7 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 2.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 6.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 27.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.8 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 2.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 0.7 | GO:0016939 | plus-end kinesin complex(GO:0005873) kinesin II complex(GO:0016939) |
0.2 | 4.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 7.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 16.9 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 6.1 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 20.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 5.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 13.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 1.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.4 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.1 | 0.9 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 2.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 3.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.1 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 4.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 4.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 2.5 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.4 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 2.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 2.0 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 1.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 1.4 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 0.8 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 13.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 2.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 1.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.7 | GO:0036019 | endolysosome(GO:0036019) endolysosome membrane(GO:0036020) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 206.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 1.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 2.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.8 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 3.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 7.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 3.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.1 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.1 | 1.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.7 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 2.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 2.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.9 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 3.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 4.4 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 2.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 3.1 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 190.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.2 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.1 | 1.9 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 3.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 2.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.0 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 1.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 1.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 53.1 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 1.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 1.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 1.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 1.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.5 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 17.9 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
3.4 | 20.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
2.5 | 7.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
2.3 | 7.0 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
2.1 | 8.6 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
1.8 | 7.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
1.7 | 5.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
1.7 | 6.7 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.6 | 6.6 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
1.6 | 14.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.5 | 7.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.4 | 5.7 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
1.3 | 1.3 | GO:0050436 | microfibril binding(GO:0050436) |
1.2 | 23.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.2 | 8.4 | GO:1990254 | keratin filament binding(GO:1990254) |
1.0 | 3.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
1.0 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.0 | 12.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
1.0 | 2.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
1.0 | 5.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.0 | 2.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.9 | 3.5 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.9 | 18.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.8 | 3.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.8 | 3.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.8 | 3.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
0.8 | 9.8 | GO:0019864 | IgG binding(GO:0019864) |
0.8 | 3.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.8 | 14.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.8 | 2.3 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.8 | 4.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.8 | 12.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.8 | 3.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 10.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 6.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.7 | 2.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 24.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.7 | 2.8 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.7 | 2.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.7 | 22.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 5.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.7 | 2.0 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.7 | 8.7 | GO:0005113 | patched binding(GO:0005113) |
0.7 | 3.3 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.6 | 5.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 1.9 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.6 | 15.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.6 | 6.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.6 | 2.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.6 | 1.8 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.6 | 11.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 3.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.6 | 6.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 4.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 2.3 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.6 | 5.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 1.1 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.6 | 2.2 | GO:0047708 | biotinidase activity(GO:0047708) |
0.5 | 8.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.5 | 3.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 23.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.5 | 8.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 4.8 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.5 | 2.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.5 | 4.2 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.5 | 3.1 | GO:0070905 | serine binding(GO:0070905) |
0.5 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 1.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.5 | 3.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.5 | 13.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 2.5 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.5 | 6.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.5 | 4.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.5 | 1.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.4 | 1.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 19.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 10.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 1.3 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.4 | 3.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.3 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.4 | 2.2 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.4 | 2.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 3.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 3.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 2.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.4 | 1.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 16.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 2.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 1.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.4 | 5.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 4.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 5.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 1.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 2.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 1.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 11.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 1.1 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
0.4 | 2.2 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.4 | 1.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 1.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.4 | 58.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 1.4 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.4 | 2.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 1.4 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.3 | 1.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.3 | 1.4 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.3 | 22.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 2.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.3 | 1.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.3 | 7.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 2.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 4.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 1.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 1.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 0.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 8.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 6.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 1.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.3 | 0.9 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.3 | 9.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 18.7 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.3 | 1.5 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 3.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 1.4 | GO:0030551 | cyclic nucleotide binding(GO:0030551) cAMP binding(GO:0030552) |
0.3 | 2.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 3.7 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.3 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 5.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 5.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 4.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 8.3 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 3.4 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.3 | 25.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 0.8 | GO:0052853 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.3 | 1.0 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 55.8 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 2.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.3 | 1.5 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.3 | 0.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 3.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 1.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 4.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.2 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.2 | 2.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 1.0 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 1.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 0.7 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.2 | 1.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 5.3 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 5.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.6 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.2 | 0.7 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.2 | 0.7 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.2 | 18.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 7.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 2.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 2.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.2 | 4.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.6 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
0.2 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 2.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 0.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 1.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.2 | 3.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.6 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 8.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 47.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 1.5 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 3.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.9 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.2 | 2.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.2 | 4.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 4.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.5 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.2 | 0.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 3.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 4.2 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.0 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.2 | 20.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.9 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.2 | 1.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 5.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 2.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.5 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 2.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 2.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 2.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.5 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.2 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 3.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 1.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.3 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.2 | 0.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.4 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 7.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.9 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 0.6 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 1.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 1.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 0.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 2.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 2.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.1 | 0.8 | GO:0030291 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 1.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.8 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.1 | 2.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 2.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 4.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 3.1 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.9 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 1.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.5 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.1 | 7.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 1.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 5.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 6.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.5 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.1 | 1.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 5.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.6 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.1 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.8 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 0.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.4 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 2.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 4.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 2.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 2.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 8.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 3.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 2.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 0.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 0.4 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 10.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 2.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 3.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 4.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.7 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.3 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 3.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 5.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 4.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 1.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 2.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 1.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 3.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 1.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.2 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 4.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 1.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 2.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.1 | 2.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 12.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.9 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.4 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 2.4 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 2.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 2.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 18.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 1.8 | GO:0016462 | pyrophosphatase activity(GO:0016462) |
0.1 | 0.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 1.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.2 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
0.1 | 2.2 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.2 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.1 | 18.6 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.1 | 0.2 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.1 | 1.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.1 | 8.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 6.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.7 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 5.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.1 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 1.4 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 1.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 1.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.9 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 5.1 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 2.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 2.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.0 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 7.2 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 4.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 1.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.0 | 0.2 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.0 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 34.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 2.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.1 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 2.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) lipoprotein particle receptor binding(GO:0070325) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 1.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 10.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 11.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 42.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 13.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 24.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 18.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 3.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 12.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 21.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 7.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 12.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 4.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 7.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 3.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 9.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 5.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 5.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 14.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 8.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 10.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 4.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 4.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 33.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 9.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 4.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 3.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 5.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 7.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 5.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 11.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 5.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 26.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 27.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 15.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 3.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 3.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 2.9 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 96.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.4 | 32.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.8 | 15.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.6 | 15.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.5 | 3.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.5 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.5 | 15.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 5.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 13.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 13.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 12.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 15.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 11.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 2.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 7.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 4.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 1.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 14.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 11.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 21.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 7.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 5.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 5.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 1.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 5.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 3.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 5.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 20.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 3.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 17.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 4.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 3.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 3.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 7.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 10.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 3.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 3.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 13.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 4.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 3.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 5.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 4.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 7.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 3.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 3.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 5.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 11.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 6.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 5.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 3.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 3.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 2.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 11.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 7.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 4.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 2.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 9.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 2.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 2.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.6 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 1.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 1.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 1.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 3.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 1.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 1.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |